Covidien launches new catheter in U.S. and EU; Meridian gets FDA OK for strep throat Dx;

 @FierceMedDev: BioFire Diagnostics pulls in $25M in new funding for accelerated product development. Release | Follow @FierceMedDev

 @MarkHFierce: The iPhone 5 could accelerate the migration of medical devices to Bluetooth, eWeek reports. More | Follow @MarkHFierce

 @DamianFierce: Medtronic is looking to pair its pump technology with the next generation of Alzheimer's drugs. Report | Follow @DamianFierce

> Covidien ($COV) has launched the Viance crossing catheter and Enteer re-entry system, designed to treat chronic total occlusions endovascularly, in the U.S. and EU. More

> Meridian Bioscience ($VIVO) got FDA approval for its new molecular diagnostic test for Group A strep throat. Item

> Sequenom ($SQNM) raised $130 million through the sale of senior notes, money the company will use to market its MaterniT21 Plus pre-natal test. Story

> AtriCure has treated its first patient with its new atrial fibrillation device, the first part of an FDA-approved pilot study. Release

> Codman & Shutleff is touting positive data for its vascular reconstruction device, a self-expanding stent designed to treat patients with wide neck saccular aneurysms. Article

> Fortune has a blow-by-blow account of Synthes' illegal tests of its bone cement. News

> Malaysia's Medical Device Authority is reforming its regulatory policies, seeking public comment on proposed new rules for devicemakers there. Report

> DFine has launched its Star tumor ablation system in the U.S. Release

> Canadian cancer diagnostics company Mitomics says it has a bright future, despite recent job cuts. More

Biotech News

 @FierceBiotech: Bedside blood infection test being developed for sepsis. Item | Follow @FierceBiotech

 @JohnCFierce: Interesting: J&J setting up 4 deal teams around the globe - Boston. California. China and London. Via ReutersReport | Follow @JohnCFierce

 @RyanMFierce: Fierce 15 arrives tomorrow. Here are some details on what to expect: More | Follow @RyanMFierce

> Medtronic dangles Alzheimer's delivery tech to frustrated pharmas. Story

> Software mogul commits $104M to CureVac's cancer vax work. More

Pharma News

 @FiercePharma: WSJ's story on the Chinese drug-price cuts: Report | Follow @FiercePharma

> Analysts eye generic threat as Vivus rolls out Qsymia. Article

> Merck yanks European app for Erbitux in lung cancer. Story

> Costly cancer drugs get the Chinese price-cutting treatment. More

Pharma Manufacturing News

> Gelatin prices look to rise steeply. Story

> Boehringer Ingelheim closing 1 of 3 U.S. API plants. More

> India says it will meet EU's API quality deadline. Report

Biotech Research News

> Mayo Clinic spies enzyme that destroys brain-clogging Alzheimer's protein. More

> Drug combo packs punch fighting rare form of melanoma in mice. Story

> UMass sensor array 'smelled' metastatic cancer cells in preclinical study. Article

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.